Search research articles
Contact Us
Filters
Showing results (131-140 of 136) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 136 results.
Leukemia
|
March 31, 2022
RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia
Justine Decroocq, Rudy Birsen, Camille Montersino, et al.
Leukemia
|
May 12, 2026
Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement
Benoit Ducourneau, Arnaud Pages, Stéphanie Struski, et al.
The Lancet. Oncology
|
August 4, 2015
Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study
Farhad Ravandi, Ellen K Ritchie, Hamid Sayar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2019
Chromosomal Abnormalities and Prognosis in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts
Linus Angenendt, Christoph Röllig, Pau Montesinos, et al.
The New England Journal of Medicine
|
January 5, 2022
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
Régis Peffault de Latour, Austin Kulasekararaj, Simona Iacobelli, et al.
Blood Advances
|
December 24, 2019
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
Francine Garnache-Ottou, Chrystelle Vidal, Sabeha Biichlé, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 136) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 136 results.
Leukemia
|
March 31, 2022
RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia
Justine Decroocq, Rudy Birsen, Camille Montersino, et al.
Leukemia
|
May 12, 2026
Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement
Benoit Ducourneau, Arnaud Pages, Stéphanie Struski, et al.
The Lancet. Oncology
|
August 4, 2015
Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study
Farhad Ravandi, Ellen K Ritchie, Hamid Sayar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2019
Chromosomal Abnormalities and Prognosis in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts
Linus Angenendt, Christoph Röllig, Pau Montesinos, et al.
The New England Journal of Medicine
|
January 5, 2022
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
Régis Peffault de Latour, Austin Kulasekararaj, Simona Iacobelli, et al.
Blood Advances
|
December 24, 2019
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
Francine Garnache-Ottou, Chrystelle Vidal, Sabeha Biichlé, et al.
Page
of 14